Mar. 13, 2019—A special lecture by Randy Blakely, Ph.D., executive director FAU Brain Institute kicks off activities celebrating Brain Awareness Month at Vanderbilt. Blakely’s talk, “When Cocaine Just Won’t Do: ADHD and Serotonin-Dopamine Crosstalk,” will be held Thursday, March 14, 10 a.m., in 214 Light Hall. Vanderbilt graduate students worked with faculty advisors to develop a series...
Dec. 16, 2016—Artificial kidneys, gay-straight alliances and junkyard batteries captured readers' attention in 2016.
Apr. 28, 2016—Researchers at Columbia and Vanderbilt universities have made an important discovery in mice that has implications for understanding the gastrointestinal (GI) problems experienced by some children with autism.
Nov. 5, 2015—Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.
Jul. 7, 2015—The partnership with Fisk through the Fisk-Vanderbilt Masters-to-PhD Bridge Program and other avenues, “presents us with an opportunity to see the results of our efforts impact an under-served community."
Oct. 23, 2014—The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.
Sep. 4, 2014—Vanderbilt University researchers have received multi-year grants from two private foundations to investigate key signaling proteins that could lead to novel treatments for autism spectrum disorder (ASD) and dystonia, a movement disorder.